Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series

Autor: Oktar Asoglu, Alisina Bulut, Vusal Aliyev, Guglielmo Niccolò Piozzi, Koray Guven, Barıs Bakır, Suha Goksel

Publikováno v: World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-11 (2022)

Abstract Aim To report long-term oncological outcomes and organ preservation rate with a chemoradiotherapy-consolidation chemotherapy (CRT-CNCT) treatment for locally advanced rectal cancer (LARC). Method Retrospective analysis of prospectively maint

Externí odkaz: https://doaj.org/article/e9e7014c84a84cec9d66eb2e17337285

Multivisceral resection for synchronous inflammatory myofibroblastic tumors of the lung and stomach

Autor: Naciye Cigdem Arslan, Suha Goksel, Oktar Asoglu

Publikováno v: Journal of Pediatric Surgery Case Reports, Vol 52, Iss , Pp - (2020)

Inflammatory myofibroblastic tumor is a mesenchymal tumor which commonly originates from lungs. In this paper we report the successful resection of multiple inflammatory myofibroblastic tumors invading thoracic, mediastinal and abdominal viscera in a

Externí odkaz: https://doaj.org/article/0fde557b4e00478f88f246cad920d99d

Total neoadjuvant treatment (consolidation chemotherapy) provides highest rate of clinical complete response for rectal cancer: analysis of 5-year long-term oncological outcomes with watch and wait protocol

Autor: Oktar Asoglu, Alisina Bulut, Vusal Aliyev, Guglielmo Niccolò Piozzi, Koray Guven, Barıs Bakır, Suha Goksel

Aim To reveal whether chemoradiotherapy-consolidation chemotherapy (CRT-CNCT) treatment provides more organ preservation in locally advanced rectal cancer (LARC) and its effect on oncological outcomes. Method Retrospective analysis of prospectively m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f105f410eaf4f828c786394fecf59a3b
https://doi.org/10.21203/rs.3.rs-2113836/v1

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

Autor: Angelita Habr-Gama, S. Ravi, R. Kushwaha, Zaman Z. Mamedli, Koen C.M.J. Peeters, Anna Martling, Elma Meershoek-Klein Kranenbarg, Geerard L. Beets, Arthur Sun Myint, S. Loganathan, Gustavo Rossi, Wolfgang Gaertner, S. Duff, J. Heat, D. Vimalchandran, Malcolm S Wilson, J. Hobbiss, K.H. Siddiqui, Krzysztof Bujko, Fernando Sanchez Loria, Maxime J M van der Valk, Rodrigo Oliva Perez, Marit E van der Sande, Renu R. Bahadoer, P. Mitchell, A. Blower, Jarno Melenhorst, Claudio Coco, J. Salaman, Guilherme Pagin São Julião, Denise E. Hilling, Oktar Asoglu, M.H. Solkar, S.H. Pettit, S.T. Dwyer, P. Vieira, Anders Jakobsen, N. Lees, Rita Barroca, Christopher M. Cunningham, Simon Gollins, S. Ward, Jean-Pierre Gerard, J. Epstein, James Hill, Albert Wolthuis, Nuno Figueiredo, A. Bhowmick, Nagarajan Pranesh, Nigel Scott, M. Braun, J. Harrison, Jing Zhang, Oriol Pares, André D’Hoore, R. Rajaganeshan, K. Riyad, R. Harris, Inês Santiago, Soledad Iseas, Paul E Fulford, Alejandro Pairola, Charlotte Verberne, B. Taylor, Des C. Winter, M. Paraoan, Annet G H Roodvoets, P. Carter, Harm J. T. Rutten, Fernando López Campos, Zhen Zhang, A. Abdelrazeq, Carlos A. Vaccaro, M. Saeed, C. Smart, Laura M. Fernandez, Carlijn Witjes, T.Y. Linn, K. Telford, Chelliah Selvasekar, D. Richards, Peirong Ding, J. Beveridge, D. Evans, Andrew G Renehan, Carlos Alfredo Lopes de Carvalho, Cornelis J.H. van de Velde, David R. Jones, Robert Madoff, Z. Huq, Sthela M. Murad-Regadas, Bruna Borba Vailati, Sarah T O'Dwyer, Klaus E. Matzel, Eduardo Huertas, L. Jones, U. Khan, S. Rawat, Gabriel Dimofte

Publikováno v: Lancet oncology, 22(1), 43-50. Elsevier Science
The Lancet Oncology, 22(1), 43-50. ELSEVIER SCIENCE INC
Lancet Oncology, 22(1), 43-50. Lancet Publishing Group

Summary Background Watch and wait is a novel management strategy in patients with rectal cancer who have a clinical complete response after neoadjuvant chemoradiotherapy. Surveillance of these patients is generally intensive, because local regrowth (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04fa7ee224e61b596bc415c8f0974dea
https://doi.org/10.1016/s1470-2045(20)30557-x

Watch and Wait Strategy for Rectal Cancer: How Long Should We Wait for a Clinical Complete Response?

Autor: Oktar, Asoglu, Beslen, Goksoy, Vusal, Aliyev, Teuta Zoto, Mustafayev, Banu, Atalar, Baris, Bakir, Koray, Guven, Gokhan, Demir, Suha, Goksel

Publikováno v: Surgical technology international. 40

The objective of this study was to determine how long to wait in locally advanced rectal tumor (LARC) patients who receive total neoadjuvant therapy (TNT) and achieve a clinical complete response (cCR), and to identify the clinical parameters that af

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::79c2c857981705534b39e5b35629bb72
https://pubmed.ncbi.nlm.nih.gov/35090178